Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Not Confirmed
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Not Confirmed
Not Confirmed
05-08 October, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Fall Technical MeetingFall Technical Meeting
Industry Trade Show
Not Confirmed
05-07 October, 2025
The MedTech ConferenceThe MedTech Conference
Industry Trade Show
Not Confirmed
05-08 October, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/we-bridge-the-gap-between-chemistry-and-performance-to-deliver-precise-optimized-micronization-for-complex-apis
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
24 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/24/3155284/0/en/Palvella-Therapeutics-Announces-Expansion-of-QTORIN-Rapamycin-s-Development-into-Clinically-Significant-Angiokeratomas-a-Rare-Chronically-Debilitating-Lymphatic-Disease-with-No-FDA.html
17 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/17/3151540/0/en/Palvella-Therapeutics-Announces-Scientific-Publication-in-Lymphatic-Research-and-Biology-Highlighting-Recent-Advances-in-the-Pathogenesis-of-Venous-Malformations-and-the-Real-World.html
15 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/15/3149883/0/en/Palvella-Therapeutics-Completes-Enrollment-in-Phase-2-TOIVA-Trial-of-QTORIN-Rapamycin-for-Cutaneous-Venous-Malformations.html
03 Sep 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/09/03/3143473/0/en/Palvella-Therapeutics-Strengthens-Leadership-with-Appointment-of-Accomplished-Scientist-and-Biopharmaceutical-Executive-David-W-Osborne-Ph-D-as-Chief-Innovation-Officer.html
28 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/28/3140696/0/en/Palvella-Therapeutics-to-Present-at-Upcoming-Healthcare-Investor-Conferences.html
14 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/14/3133348/0/en/Palvella-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Provides-Corporate-Update.html
ABOUT THIS PAGE